Search

everythinglearnresearchcommunity

for

Search:↓

The compounds tested could potentially treat hair loss and alopecia.

Neurosteroids regulate synaptic inhibition in the spinal cord and may help manage spinal pain.

Dutasteride effectively treats enlarged prostate with manageable side effects.

Finasteride reduces movement issues in Parkinson's disease rats.

Strontium ranelate helps cartilage growth by blocking a specific cell pathway.

Using a certain drug on the skin can help prevent hair loss caused by pulling on the hair.

Avicennia Marina extract and avicequinone C can reduce hair loss hormone production and increase hair growth factors, suggesting they could be used to treat androgenic alopecia.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

Low-dose naltrexone helps reduce symptoms and slow down lichen planopilaris without side effects.

Finasteride increases CD8+ T cells in BPH tissues.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

Brimonidine is effective for reducing facial redness in skin conditions and has potential for broader dermatological uses.

Targeting the RAAS with small molecules can improve cardiovascular disease treatments.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Sodium valproate is not recommended as a first-line treatment for neuropathy but may be used in resistant cases.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Both VEPA and ML-Y1 treatments are not effective enough for elderly non-Hodgkin's lymphoma patients.

Lignans from Urtica triangularis may help treat benign prostatic hyperplasia (BPH).

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

Setipiprant did not significantly improve hair growth in men with hair loss.

Aromoline and DRD4 are potential targets for osteoarthritis treatment.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Minoxidil might partially activate estrogen receptors, affecting hair growth.

Dobutamine does not mimic dopamine at therapeutic doses but may at very high concentrations; microfilaments, not microtubules, are important for wound healing in Xenopus embryos.